Generation and evaluation of a chimeric antibody against coxsackievirus and adenovirus receptor for cancer therapy
Open Access
- 11 September 2019
- journal article
- research article
- Published by Wiley in Cancer Science
- Vol. 110 (11) , 3595-3602
Abstract
Coxsackievirus and adenovirus receptor (CAR) is a single‐pass transmembrane protein that is associated with adenoviral infection. CAR is involved in the formation of epithelial tight junctions and promotes tumor growth in some cancers. Previously, we developed mouse monoclonal antibodies against human CAR and found that one, mu6G10A, significantly inhibited tumor growth in xenografts of human cancer cells. Herein, we generated and characterized a mouse‐human chimeric anti‐CAR antibody (ch6G10A) from mu6G10A. ch6G10A had binding activity, inducing antibody‐dependent cellular cytotoxicity and complement‐dependent cytotoxicity, and in vivo anti‐tumor activity against CAR‐expressing prostate cancer DU‐145 cells. In addition, cancer tissue array analysis confirmed that CAR is highly expressed in neuroendocrine lung cancers including small cell lung cancer, and treatment with ch6G10A effectively inhibited in vivo subcutaneous tumor growth of NCI‐H69 small cell lung cancer cells in nude mice. Moreover, treatment with mu6G10A effectively inhibited both in vivo orthotopic tumor growth and distant metastatic formation in mouse xenograft models of a highly metastatic subline of human small cell lung cancer DMS273 cells. These results suggest that targeting therapy to CAR with a therapeutic antibody might be effective against several cancer types including small cell lung cancer.Keywords
Funding Information
- Kobayashi Foundation for Cancer Research
- Japan Society for the Promotion of Science (26460481, 17K08777)
This publication has 22 references indexed in Scilit:
- Expression of the coxsackie adenovirus receptor in neuroendocrine lung cancers and its implications for oncolytic adenoviral infectionCancer Gene Therapy, 2012
- Essential Role of the Coxsackie - and Adenovirus Receptor (CAR) in Development of the Lymphatic System in MicePLOS ONE, 2012
- Evaluation of coxsackievirus and adenovirus receptor expression in human benign and malignant thyroid lesionsAPMIS, 2010
- Expression of coxsackie and adenovirus receptor in small cell lung cancerThe Chinese-German Journal of Clinical Oncology, 2009
- Coxsackievirus and adenovirus receptor expression in human endometrial adenocarcinoma: possible clinical implicationsWorld Journal of Surgical Oncology, 2008
- Neuroblastomas and medulloblastomas exhibit more Coxsackie adenovirus receptor expression than gliomas and other brain tumorsNeuropathology, 2007
- Coxsackievirus and adenovirus receptor expression in non-malignant lung tissues and clinical lung cancersJournal of Molecular Histology, 2006
- Coxsackievirus-adenovirus receptor (CAR) is essential for early embryonic cardiac developmentJournal of Cell Science, 2005
- Coxsackie and Adenovirus Receptor Promotes Adenocarcinoma Cell Survival and Is Expressionally Activated after Transition from Preneoplastic Precursor Lesions to Invasive AdenocarcinomasClinical Cancer Research, 2005
- CAR: A virus receptor within the tight junctionAdvanced Drug Delivery Reviews, 2005